{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:15:23Z","timestamp":1771067723962,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1008773"],"award-info":[{"award-number":["NRF-2019R1A2C1008773"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111297","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T12:26:30Z","timestamp":1611318390000},"page":"111297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Gemigliptin suppresses salivary dysfunction in streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"137","author":[{"given":"Wan Seok","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Kwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111297_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4372852","article-title":"Xerostomia, hyposalivation, and salivary flow in diabetes patients","volume":"2016","author":"L\u00f3pez-Pintor","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/2321-4848.144335","article-title":"Xerostomia: Few dry facts about dry mouth","volume":"2","author":"Rao","year":"2014","journal-title":"Arch. Med. Health Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111297_bib0015","first-page":"289","article-title":"Retroviruses in autoimmune liver disease: genetic or environmental agents?","volume":"47","author":"Mason","year":"1999","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0757.2006.00193.x","article-title":"Diabetes mellitus and periodontal disease","volume":"44","author":"Mealey","year":"2007","journal-title":"Periodontology 2000"},{"issue":"3","key":"10.1016\/j.biopha.2021.111297_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-0528.2002.300304.x","article-title":"Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population","volume":"30","author":"Tsai","year":"2002","journal-title":"Community Dent. Oral Epidemiol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111297_bib0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1902\/jop.1994.65.11.1067","article-title":"Association of the severity of periodontal disease with organ complications in type 1 diabetic patients","volume":"65","author":"Karjalainen","year":"1994","journal-title":"J. Periodontol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111297_bib0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1600-051X.1996.tb02076.x","article-title":"Medical status and complications in relation to periodontal disease experience in insulin\u2010dependent diabetics","volume":"23","author":"Thorstensson","year":"1996","journal-title":"J. Clin. Periodontol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.archoralbio.2014.10.004","article-title":"Salivary hypofunction: an update on aetiology, diagnosis and therapeutics","volume":"60","author":"Saleh","year":"2015","journal-title":"Arch. Oral Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111297_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1742-1241.2009.02132.x","article-title":"Managing the patient presenting with xerostomia: a review","volume":"64","author":"Visvanathan","year":"2010","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0030-4220(70)90011-3","article-title":"Alteration in parotid salivary flow in diabetes mellitus","volume":"30","author":"Conner","year":"1970","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111297_bib0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.dsx.2009.08.004","article-title":"Oral health in Thai patients with metabolic syndrome","volume":"3","author":"Chomkhakhai","year":"2009","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.18295\/2075-0528.1261","article-title":"Oral manifestations and complications of diabetes mellitus: a review","volume":"11","author":"Al-Maskari","year":"2011","journal-title":"Sultan Qaboos Univ. Med. J."},{"issue":"9","key":"10.1016\/j.biopha.2021.111297_bib0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.archoralbio.2015.06.012","article-title":"Antioxidant profile, carbonyl and lipid oxidation markers in the parotid and submandibular glands of rats in different periods of streptozotocin induced diabetes","volume":"60","author":"Zalewska","year":"2015","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.biopha.2021.111297_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4583742","article-title":"Oxidative damage to the salivary glands of rats with streptozotocin-induced diabetes-temporal study: oxidative stress and diabetic salivary glands","volume":"2016","author":"Kna\u015b","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"6779","key":"10.1016\/j.biopha.2021.111297_bib0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2021.111297_bib0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00400231","article-title":"Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats","volume":"36","author":"Cameron","year":"1993","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2021.111297_bib0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/food.19950390402","article-title":"Effect of intake of exogenous vitamins C, E and \u03b2\u2010carotene on the antioxidative status in kidneys of rats with streptozotocin\u2010induced diabetes","volume":"39","author":"Meki\u0148ov\u00e1","year":"1995","journal-title":"Food Nahrung"},{"key":"10.1016\/j.biopha.2021.111297_bib0090","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/s001250051422","article-title":"Cytosolic NADH\/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus","volume":"40","author":"Ido","year":"1997","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00240060","article-title":"Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy","volume":"160","author":"Kaul","year":"1996","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.biopha.2021.111297_bib0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-0714.2006.00469.x","article-title":"Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients","volume":"35","author":"Arana","year":"2006","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3945\/ajcn.2009.27491","article-title":"Effects of vitamins C and E and \u03b2-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial","volume":"90","author":"Song","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2008-2231-20-56","article-title":"Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats","volume":"20","author":"Ghamarian","year":"2012","journal-title":"Daru"},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.111297_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12272-013-0171-x","article-title":"Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry","volume":"36","author":"Kim","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111297_bib0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s12272-016-0813-x","article-title":"DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control","volume":"39","author":"Bae","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2021.111297_bib0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2015.04.055","article-title":"Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy","volume":"761","author":"Jung","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111297_bib0135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4093\/dmj.2018.0181","article-title":"Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome","volume":"43","author":"Seo","year":"2019","journal-title":"Diabetes Metab. J."},{"issue":"1-2","key":"10.1016\/j.biopha.2021.111297_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.04.017","article-title":"Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes","volume":"392","author":"Hwang","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2021.111297_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2015.07.005","article-title":"Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation","volume":"73","author":"Choi","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111297_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2015.04.005","article-title":"Salivary biomarkers of oxidative stress: a critical review","volume":"85","author":"Wang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2010.12.021","article-title":"Effect of alogliptin, pioglitazone and glargine on pancreatic beta-cells in diabetic db\/db mice","volume":"404","author":"Kawashima","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2021.111297_bib0160","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.bbadis.2015.09.010","article-title":"Gemigliptin, a dipeptidyl peptidase-4 inhibitor, inhibits retinal pericyte injury in db\/db mice and retinal neovascularization in mice with ischemic retinopathy","volume":"1852","author":"Jung","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2021.111297_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2015.04.055","article-title":"Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy","volume":"761","author":"Jung","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/meta.2003.50014","article-title":"Enteroinsular axis of db\/db mice and efficacy of dipeptidyl peptidase IV inhibition","volume":"52","author":"Nagakura","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2021.111297_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/538737","article-title":"Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals","volume":"2014","author":"Marques","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.biopha.2021.111297_bib0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0034-1371892","article-title":"Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis","volume":"46","author":"Nakashima","year":"2014","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/jpet.111.186866","article-title":"Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats","volume":"340","author":"Liu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0190","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jcp.27164","article-title":"A review of the molecular mechanisms of hyperglycemia\u2010induced free radical generation leading to oxidative stress","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7\u20138","key":"10.1016\/j.biopha.2021.111297_bib0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.exger.2010.01.003","article-title":"The sites and topology of mitochondrial superoxide production","volume":"45","author":"Brand","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111297_bib0200","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1016\/j.cub.2012.12.011","article-title":"ROS","volume":"23","author":"Glasauer","year":"2013","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111297_bib0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.111297_bib0210","first-page":"159","article-title":"Saliva as a diagnostic fluid","volume":"55","author":"Malamud","year":"2011","journal-title":"Dent. Clin."},{"issue":"10","key":"10.1016\/j.biopha.2021.111297_bib0215","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/nu10101530","article-title":"Eight-week consumption of high-sucrose diet has a pro-oxidant effect and alters the function of the salivary glands of rats","volume":"10","author":"Maciejczyk","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2021.111297_bib0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11427-018-9318-8","article-title":"Aquaporin 5 is degraded by autophagy in diabetic submandibular gland","volume":"61","author":"Huang","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2021.111297_bib0225","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.clinthera.2008.10.013","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study","volume":"30","author":"Lim","year":"2008","journal-title":"Clin. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:15:07Z","timestamp":1760098507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S0753332221000822"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111297","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemigliptin suppresses salivary dysfunction in streptozotocin-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111297"}}